Monday, June 1, 2009

Mediquest Therapeutics Gets $2.3M

Bellevue-based Mediquest Therapeutics, which is developing products for the topical treatment of inflammatory and infectious diseases, has apparently raised $2.3M of an ongoing, $15M equity funding round, according to a regulatory filing from the firm today. No details on the funding have been released by the firm. Mediquest is venture backed by Novo A/S, Janus, Integra Ventures and Masa Life Science Ventures. The firm last announced a funding back in June of 2006, when it pulled in $16.0M in a Series A funding. More information »